Falmouth-based pump manufacturer Watson-Marlow Pumps Group (WMPG) has expanded its business with the acquisition of Bio Pure Technology Limited.
The deal strengthens WMPG’s ‘single-use biopharmaceutical’ offering and was completed through its parent company, Spirax-Sarco Engineering plc, for £8.5 million.
Bio Pure, based in Portsmouth, specialises in the design and production of advanced single-use tubing connector systems for biopharmaceutical customers.
WMPG president, Jay Whalen, said: “The strategic acquisition of Bio Pure further broadens our product range and strengthens Watson-Marlow’s position in the single-use biopharmaceutical market.
“This is yet another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise.”